---
figid: PMC9005294__JO2022-5871188.002
pmcid: PMC9005294
image_filename: JO2022-5871188.002.jpg
figure_link: /pmc/articles/PMC9005294/figure/fig2/
number: Figure 2
figure_title: ''
caption: '(a) Gene expression profiles of WDHD1 in different tumor tissues and paired
  normal tissues, and the Y axis represents the median expression of WDHD1 in some
  tumor types or normal tissues. (b) Difference of expression levels of WDHD1 in esophageal
  cancer and paired normal tissues; the Y axis represents the relative expression
  amount of WDHD1, âˆ—P < 0.05. ACC: adrenocortical carcinoma; BLCA: bladder urothelial
  carcinoma; BRCA: breast invasive carcinoma; CESC: cervical squamous cell carcinoma
  and endocervical adenocarcinoma; CHOL: cholangio carcinoma; COAD: colon adenocarcinoma;
  ESCA: esophageal carcinoma; GBM: glioblastoma multiforme; HNSC: head and neck squamous
  cell carcinoma; LUAD: lung adenocarcinoma; OV: ovarian serous cystadenocarcinoma;
  PAAD: pancreatic adenocarcinoma; READ: rectum adenocarcinoma; SARC: sarcoma; SKCM:
  skin cutaneous melanoma; STAD: stomach adenocarcinoma; TGCT: testicular germ cell
  tumors; UCEC: uterine corpus endometrial carcinoma; UCS: uterine carcinosarcoma.'
article_title: The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as
  a Downstream Target of PI3K/AKT Pathway.
citation: Qingying Xian, et al. J Oncol. 2022;2022:5871188.
year: '2022'

doi: 10.1155/2022/5871188
journal_title: Journal of Oncology
journal_nlm_ta: J Oncol
publisher_name: Hindawi

keywords:
---
